North East and North Cumbria
ICS Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Recent Updates - Updated items
All Formulary Amendments
Records 1 to 11 of 11
Details
UPD
sitematrix Changed from 0 to
10/10/2023 13:18:22
(DavidS )
UPD
Omalizumab (Xolair
®
) addition of brand
10/10/2023 13:18:22
(DavidS )
UPD
sitematrix Changed from 0 to
10/10/2023 13:17:41
(DavidS )
UPD
FurtherInformation Changed from
Only approved for use in accordance with NICE guidance.
to
75mg/0.5ml & 150mg/1ml solution for injection (pre-filled device
10/10/2023 13:17:41
(DavidS )
UPD
Omalizumab addition of formulation info
10/10/2023 13:17:41
(DavidS )
LDL
Link Added : NICE TA678: Omalizumab for treating chronic rhinosinusitis with nasal polyps (terminated appraisal) : https://www.nice.org.uk/guidance/ta678
05/07/2023 13:51:31
(ebeavers )
UPD
Omalizumab updated
25/04/2019 14:53:05
(DavidS )
UPD
Omalizumab b
27/01/2017 09:33:12
(WhitehallJ )
UPD
Omalizumab b
17/01/2017 11:48:53
(LoweryM )
UPD
Omalizumab b
17/01/2017 09:08:11
(LoweryM )
UPD
Omalizumab Build
24/11/2016 15:13:44
(ClarkH )